Search
Neutrophil-Lymphocyte Ratio (NLR) as a Prognostic Marker in Advanced Lung Cancer Patients Undergoing First-Line Treatment
209-213
Abstract : 446
PDF : 144
Profil Pasien Kanker Paru Primer yang Dirawat Inap dan Rawat Jalan di Rumah Sakit Umum Daerah Dr Soetomo Surabaya [Profile of Primary Lung Cancer Patients in Dr. Soetomo General Hospital Surabaya]
65-71
Abstract : 2083
PDF : 3884
The Influence of Nigella sativa on the Increase of IFN-γ and Quality of Life in Lung Cancer Patients Undergoing Chemotherapy
31-38
Abstract : 447
PDF : 112
Volatile Organic Compounds (VOC) and Serum Leukotriene B4 between COPD Patients and COPD with Lung Cancer Patients
222-227
Abstract : 319
PDF : 167
The Effect of Anemia on Prognostic in Non-Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy
120-129
Abstract : 437
PDF : 238
Assessment of Quality of Life in Advanced-Stage Lung Cancer Patients Using EORTC QLQ-C30 Questionnaire
228-235
Abstract : 405
PDF : 197
Risk Factors and Challenging Management of Lung Adenocarcinoma in Young Adult Women: Case Series
94-98
Abstract : 1032
PDF : 431
Efek Samping Hematologi Akibat Kemoterapi dan Tatalaksananya [Hemathologic Adverse Effect Related to Chemotherapy]
22-28
Abstract : 3963
PDF : 49546
Hematologic Paraneoplastic Syndrome in Newly Diagnosed Patients with Lung Cancer
18-29
Abstract : 805
PDF : 631
Giant Cell Lung Carcinoma: A Case Report of a Rare Histology Type of Non-Small Cell Lung Cancer
143-148
Abstract : 501
PDF : 252
The Effects of Inspiratory Muscle Training in Lung Cancer Patients: A Scoping Review
75-82
Abstract : 209
PDF : 130
Anaplastic Lymphoma Kinase (ALK) Rearrangement of Lung Adenocarcinoma among North Sumatera Population
47-53
Abstract : 165
PDF : 90
The Time to Progression in Lung Adenocarcinoma Patients Receiving First- and Second-Generation EGFR-TKI in Indonesia
22-30
Abstract : 384
PDF : 153
Implementing Palliative and End-of-Life Care in Lung Cancer: When to Start?
64-71
Abstract : 696
PDF : 534
Nutrisi pada Penderita Kanker Paru [Nutrition Management in Lung Cancer Patients]
91-100
Abstract : 2277
PDF : 15217
Volatile Organic Compounds (VOCs) and Interleukin-23 Levels in Lung Cancer: A Future Biomarker
80-86
Abstract : 724
PDF : 440
Problem Penegakkan Diagnostik Pasien dengan Massa di Paru [Diagnostic Problems in Lung Mass Management]
41-46
Abstract : 1592
PDF : 21878